Precise treatment of colorectal cancer liver metastasis guided by multi-omics data

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036696

Enrollment

Unknown

Registered

2020-08-24

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-70 years; 2) ECOG score 0-2; 3) patients with pathologically confirmed colorectal cancer; 4) combined with imaging-confirmed liver metastasis, and lesions can be measured (RECIST standard); 5) lesions are available; 6) sign a written informed consent form to participate in the trial.

Exclusion criteria

Exclusion criteria: 1) The merger has brain metastasis; 2) has a history of other malignancies; 3) pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
objective response rate;	—

Secondary

Measure	Time frame
disease control rate;progress-free survival;overall survival;	—

Countries

China

Contacts

Public ContactYe Wei

Fudan University Zhongshan Hospital

13818661815@126.com+86 13818661815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026